TP53 and prostate carcinoma: It was shown that the combination of LY294002 with GTP further increased apoptosis in cancer cells, particularly in LNCaPshV cells, confirming the independent involvement of Akt/BAD pathways in GTP-induced apoptosis of p53 inactivated prostate cancer cells.